Determination of rosuvastatin in urine by HPLC-MS/MS assay and study on its pharmacokinetics in healthy subjects

Chinese Pharmaceutical Journal

Volumn 42, Issue 15, 2007, Pages

  Tian, Lei ^a   Jiang, Juan Juan ^a   Huang, Yi Ling ^a   Liu, Hong ^a   Han, Lu Lu ^a   Xu, Li ^a   Li, Yi Shi ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Ethnic difference; HPLC MS MS; Pharmacokinetics; Rosuvastatin

Indexed keywords

FORMIC ACID; METHANOL; ROSUVASTATIN; TERT BUTYL METHYL ETHER;

ARTICLE; CONTROLLED STUDY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG URINE LEVEL; ELECTROSPRAY; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; NORMAL HUMAN; QUANTITATIVE ANALYSIS; URINALYSIS;

EID: 34548098719     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. BROWN W V, BAYS H E, HASSMAN D R, et al. Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: A randomized, double-blind, 52-week trial[J]. Am Heart J,2002,144:1036-1043.
2. HULL C K, PENMAN A D, SMITH C K, et al. Quantification of rosuvastatin in human plasma by automated solid-phase extraction using tandem mass spectrometric detection[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2002,772(2):219-228.
3. OUDHOFF K A, SANGSTER T, THOMAS E, et al. Application of mierobore HPLC in combination with tandem MS for the quantification of rosuvastatin in human plasma[J]. J Chromatogr B Analyt Technol Biomed Life Sci,2006,832(2):191-196.
4. HULL C K, MARTIN P D, WARWICK M J, et al. Quantification of the N-desmethyl metabolite of rosuvastatin in human plasma by automated SPE followed by HPLC with tandem MS detection[J]. J Pharm Biomed Anal,2004,35(3):609-614.
5. LEE E, RYAN S, BIRMINGHAM B, et al. Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment[J]. Clin Pharmacol Ther,2005,78(4):330-341.
6. MARTIN P D, WARWICK M J, DANE A L, et al. A double-blind, randomized, incomplete crossover trial to assess the dose proportionality of rosuvastatin in healthy volunteers[J]. Clin Ther,2003,25(8):2215-2224.
7. MARTIN P D, WARWICK M J, DANE A L, et al. Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers[J]. Clin Ther, 2003,25(10):2553-2563.